FDA Adverse Event Injury Summary report: N

EDWARDS INSPIRIS RESILIA AORTIC VALVE

MDR report key: 12625717 · Received October 13, 2021

Report

Report Number
2015691-2021-05652
Event Type
Injury
Date Received
October 13, 2021
Date of Event
September 10, 2021
Report Date
October 13, 2021
Manufacturer
EDWARDS LIFESCIENCES
Product Code
LWR
PMA / PMN Number
P150048
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE SUBJECT DEVICE IS NOT AVAILABLE FOR EVALUATION AS IT REMAINS IMPLANTED IN THE PATIENT. THE INVESTIGATION IS STILL IN PROGRESS; THEREFORE, A CONCLUSION HAS YET TO BE ESTABLISHED. A SUPPLEMENTAL REPORT WILL BE SUBMITTED ACCORDINGLY UPON INVESTIGATION COMPLETION. EDWARDS WILL CONTINUE TO REVIEW AND MONITOR ALL REPORTED EVENTS. TRENDS ARE MONITORED ON A MONTHLY BASIS AND IF ACTION IS REQUIRED, APPROPRIATE INVESTIGATION WILL BE PERFORMED.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT UNDERWENT IMPLANT OF A 25MM 11500A INSPIRIS VALVE. A LARGE JET WAS OBSERVED AT THE ANTERIOR STENT POST. THE JET DID NOT RESOLVE WITH PROTAMINE ADMINISTRATION. THERE WAS NO SIGNIFICANT GRADIENT AND NO PVL. THE PATIENT IS REPORTED TO BE DOING WELL. AS REPORTED, IF THE JET DOES NOT RESOLVE IN ONE MONTH THE PLAN IS FOR THE PATIENT TO UNDERGO REPLACEMENT OF THE INSPIRIS VALVE. THE PATIENT HAD TRANSIENT POST-OPERATIVE ATRIAL FIBRILLATION TREATED WITH AMIODARONE. THE PATIENT WAS DISCHARGED ON POD # 13. NO OTHER DETAILS WERE PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1520558 EDWARDS INSPIRIS RESILIA AORTIC VALVE REPLACEMENT HEART-VALVE LWR EDWARDS LIFESCIENCES 11500 NA

Patients

Seq Age Sex Outcome Treatment
1 60 YR